GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prenetics Global Ltd (NAS:PRE) » Definitions » Beta

Prenetics Global (Prenetics Global) Beta : N/A (As of May. 12, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Prenetics Global Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-12), Prenetics Global's Beta is Not available.


Prenetics Global Beta Historical Data

The historical data trend for Prenetics Global's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prenetics Global Beta Chart

Prenetics Global Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beta
- - - - -

Prenetics Global Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Prenetics Global's Beta

For the Diagnostics & Research subindustry, Prenetics Global's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prenetics Global's Beta Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prenetics Global's Beta distribution charts can be found below:

* The bar in red indicates where Prenetics Global's Beta falls into.



Prenetics Global Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Prenetics Global  (NAS:PRE) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Prenetics Global Beta Related Terms

Thank you for viewing the detailed overview of Prenetics Global's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Prenetics Global (Prenetics Global) Business Description

Traded in Other Exchanges
N/A
Address
Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong, HKG
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.

Prenetics Global (Prenetics Global) Headlines

From GuruFocus

Prenetics Rings the Opening Bell and Debuts on Nasdaq

By GuruFocusNews GuruFocusNews 06-28-2022

Prenetics Rings the Opening Bell and Debuts on Nasdaq

By GuruFocusNews GuruFocusNews 06-07-2022

Prenetics Rings the Opening Bell and Debuts on Nasdaq

By GuruFocusNews GuruFocusNews 05-18-2022

Prenetics Rings the Opening Bell and Debuts on Nasdaq

By GuruFocusNews GuruFocusNews 06-17-2022

Prenetics Rings the Opening Bell and Debuts on Nasdaq

By GuruFocusNews GuruFocusNews 05-28-2022

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

By Stock market mentor Stock market mentor 01-19-2023